Literature DB >> 8622896

Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion.

U Knippschild1, M Oren, W Deppert.   

Abstract

We used clone 6 cells (rat embryo fibroblasts transformed by the temperature sensitive mutant p53val135 and an activated H-ras-gene (Michalovitz et al., 1990)), growth arrested at 32 degrees C, as a model to analyse whether and how transformed cells, growth-arrested by an overexpressed wild-type p53, might overcome p53-mediated growth inhibition. When clone 6 cells were kept at 32 degrees C for about 2 weeks, foci of cells appeared which grew temperature-independent. Analysis of individual clones of such cell demonstrated that the ectopically expressed tsp53-gene had not been altered by an additional mutation, but that the tsp53 in these cells at 32 degrees C had lost its ability to upregulate expression of the p53 target genes waf1 and mdm2. This loss of p53-specific transactivation correlated with nuclear exclusion of the tsp53 at 32 degrees C, which was most likely mediated by cytoplasmic retention of the tsp53 protein via short-lived anchor proteins. Cytoplasmic retention of the tsp53 at 32 degrees C was also observed in PC12 pheochromocytoma cells ectopically expressing tsp53val135, there occurring without specific selection. Also in these cells nuclear exclusion of the tsp53 correlated with loss of p53 mediated growth inhibition. Nuclear exclusion of p53 thus might serve as an epigenetic mechanism to eliminate the growth-inhibitory function of p53.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622896

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Regulation of ES cell differentiation by functional and conformational modulation of p53.

Authors:  K Sabapathy; M Klemm; R Jaenisch; E F Wagner
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  Senescence-associated alterations of cytoskeleton: extraordinary production of vimentin that anchors cytoplasmic p53 in senescent human fibroblasts.

Authors:  Koji Nishio; Akira Inoue
Journal:  Histochem Cell Biol       Date:  2005-03-02       Impact factor: 4.304

3.  Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.

Authors:  Antonino B D'Assoro; Alexey Leontovich; Angela Amato; Jennifer R Ayers-Ringler; Cosima Quatraro; Kari Hafner; Robert B Jenkins; Massimo Libra; James Ingle; Franca Stivala; Evanthia Galanis; Jeffrey L Salisbury
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

4.  Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo.

Authors:  Georgios Giamas; Heidrun Hirner; Levani Shoshiashvili; Arnhild Grothey; Susanne Gessert; Michael Kühl; Doris Henne-Bruns; Constantinos E Vorgias; Uwe Knippschild
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

5.  Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.

Authors:  A Nickels; H Selter; M Pfreundschuh; M Montenarh; B Koch
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 6.  The role of p53 in human cancer.

Authors:  D Malkin
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

7.  Mice defective in p53 nuclear localization signal 1 exhibit exencephaly.

Authors:  Anouk Regeling; Heather L Armata; Judy Gallant; Stephen N Jones; Hayla K Sluss
Journal:  Transgenic Res       Date:  2010-12-03       Impact factor: 2.788

8.  BK virus as a cofactor in the etiology of prostate cancer in its early stages.

Authors:  Dweepanita Das; Kirk Wojno; Michael J Imperiale
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

9.  Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.

Authors:  Camille Brochier; Gretel Dennis; Mark A Rivieccio; Kathryn McLaughlin; Giovanni Coppola; Rajiv R Ratan; Brett Langley
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

10.  Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs.

Authors:  Liwei Rong; Mark Livingstone; Rami Sukarieh; Emmanuel Petroulakis; Anne-Claude Gingras; Katherine Crosby; Bradley Smith; Roberto D Polakiewicz; Jerry Pelletier; Maria A Ferraiuolo; Nahum Sonenberg
Journal:  RNA       Date:  2008-05-30       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.